Advancement in the research of mechanism of immune dysfunction in sepsis and the regulatory effects of Xuebijing injection

Chinese Journal of Burns

Volumn 29, Issue 2, 2013, Pages 162-165

  Gao, Yu Lei ^a   Chai, Yan Fen ^a   Yao, Yong Ming ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Immunity; Sepsis; Treatment; Xuebijing injection

Indexed keywords

CHINESE DRUG; ENDOTOXIN; UNCLASSIFIED DRUG; XUEBIJING INJECTION;

ARTICLE; BACTERIOSTASIS; DENDRITIC CELL; HOSPITAL INFECTION; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTESTINE MUCOSA; LYMPHOID TISSUE; MULTIPLE ORGAN FAILURE; REGULATORY T LYMPHOCYTE; SEPSIS; T LYMPHOCYTE; VIRUS REACTIVATION;

DRUGS, CHINESE HERBAL; HUMANS; IMMUNOMODULATION; SEPSIS;

EID: 84880408224     PISSN: 10092587     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1009-2587.2013.02.017     Document Type: Article

References (34)

1. Muenzer JT, Davis CG, Chang K, et al. Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun, 2010,78(4):1582-1592.
2. Ocuin LM, Bamboat ZM, Balachandran VP, et al. Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis. J Leukoc Biol, 2011,89(3):423-432.
3. Brogliato AR, Antunes CA, Carvalho RS, et al. Ketoprofen impairs immunosuppression induced by severe sepsis and reveals an important role for prostaglandin E2. Shock, 2012,38(6):620-629.
4. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA, 2008,300(4):413-422. (Pubitemid 352040253)
5. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA, 2011,306(23):2594-2605.
6. Winters BD, Eberlein M, Leung J, et al. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med, 2010,38(5):1276-1283.
7. Heidecke CD, Hensler T, Weighardt H, et al. Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg, 1999,178(4):288-292.
8. Carchman EH, Rao J, Loughran PA, et al. Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology, 2011,53(6):2053-2062.
9. Chang KC, Unsinger J, Davis CG, et al. Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J, 2007,21(3):708-719. (Pubitemid 46348247)
10. Souza-Fonseca-Guimaraes F, Parlato M, Fitting C, et al. NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis. J Immunol, 2012,188(12):5850-5858.
11. Chougnet CA, Tripathi P, Lages CS, et al. A major role for Bim in regulatory T cell homeostasis. J Immunol, 2011,186(1):156-163.
12. Hansen W, Hutzler M, Abel S, et al. Neuropilin 1 deficiency on CD4 + Foxp3 + regulatory T cells impairs mouse melanoma growth. J Exp Med, 2012,209(11):2001-2016.
13. Saito K, Wagatsuma T, Toyama H, et al. Sepsis is characterized by the increases in percentages of circulating CD4 + CD25 + regulatory T cells and plasma levels of soluble CD25. Tohoku J Exp Med, 2008,216(1):61-68.
14. Heuer JG, Zhang T, Zhao J, et al. Adoptive transfer of in vitro-stimulated CD4 + CD25 + regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol, 2005,174(11):7141- 7146. (Pubitemid 40705680)
15. Ni Choileain N, MacConmara M, Zang Y, et al. Enhanced regulatory T cell activity is an element of the host response to injury. J Immunol, 2006,176(1):225-236. (Pubitemid 43023267)
16. MacConmara MP, Maung AA, Fujimi S, et al. Increased CD4 + CD25 + T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg, 2006,244(4):514-523.
17. Scumpia PO, Delano MJ, Kelly KM, et al. Increased natural CD4 + CD25 + regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol, 2006,177(11):7943-7949. (Pubitemid 44846310)
18. Chen X, Murakami T, Oppenheim JJ, et al. Differential response of murine CD4 + CD25 + and CD4 + CD25- T cells to dexamethasone-induced cell death. Eur J Immunol, 2004,34(3):859-869. (Pubitemid 39255934)
19. Chen X, Bäumel M, Männel DN, et al. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4 + CD25 + T regulatory cells. J Immunol, 2007,179(1):154-161. (Pubitemid 46986529)
20. Liu QY, Yao YM, Zhang SW, et al. Naturally existing CD11c(low) CD45RB(high) dendritic cells protect mice from acute severe inflammatory response induced by thermal injury. Immunobiology, 2011,216(1/2):47-53.
21. Liu QY, Yao YM, Yan YH, et al. High mobility group box 1 protein suppresses T cell-mediated immunity via CD11c(low) CD45RB(high) dendritic cell differentiation. Cytokine, 2011,54(2):205-211.
22. Hemmer CJ, Vogt A, Unverricht M, et al. Malaria and bacterial sepsis: similar mechanisms of endothelial apoptosis and its prevention in vitro. Crit Care Med, 2008,36(9):2562-2568.
23. Coopersmith CM, Stromberg PE, Dunne WM, et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA, 2002,287(13):1716-1721. (Pubitemid 34289225)